Cargando…
Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
Recurrent vulvovaginal candidiasis (RVVC) is a widespread chronic infection that has a substantial negative impact on work and quality of life. The development of antimicrobial resistance and biofilm formation are speculated to contribute to Candida pathogenicity and treatment ineffectiveness. Desig...
Autores principales: | Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811422/ https://www.ncbi.nlm.nih.gov/pubmed/31451496 http://dx.doi.org/10.1128/AAC.02690-18 |
Ejemplares similares
-
Designed Antimicrobial Peptides for Topical Treatment of Antibiotic Resistant Acne Vulgaris
por: Woodburn, Kathryn W., et al.
Publicado: (2020) -
Designed Antimicrobial Peptides Against Trauma-Related Cutaneous Invasive Fungal Wound Infections
por: Woodburn, Kathryn W., et al.
Publicado: (2020) -
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022) -
Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm
por: Woodburn, Kathryn Wynne, et al.
Publicado: (2019) -
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
por: Rosati, Diletta, et al.
Publicado: (2020)